• Revvity Inc RVTY.N reported quarterly adjusted earnings of $1.18​​ per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of $1.28. The mean expectation of eighteen analysts for the quarter was for earnings of $1.14 per share. Wall Street expected results to range from $1.12 to $1.16 per share.

• Revenue rose 2.2% to $698.95 million from a year ago; analysts expected $700.46 million.

• Revvity Inc's reported EPS for the quarter was 40 cents​.

• The company reported quarterly net income of $46.65 million.

• Revvity Inc shares had risen by 12.8% this quarter and lost 11.4% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 1.6% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy," 6 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

• Wall Street's median 12-month price target for Revvity Inc is $115.00, about 14% above its last closing price of $98.89

This summary was machine generated from LSEG data October 27 at 05:41 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)